According to a 2024 report by Grand View Research, the global microneedle market is projected to reach $13.8 billion by 2030 , growing at a CAGR of 16.7% from 2024 to 2030
We understand that losing weight involves more than numbers on a scale
Evidence in humans is early, so peptide therapy should complement, not replace, established rheumatology care
A low-serum level of IGF-1 has been associated with insulin resistance, and [...] recombinant IGF-1 has been [hypothesized] to improve insulin sensitivity and glucose metabolism. Receptor Grade IGF-1 LR3 and Cell Lifespan Research (6) on murine models observed that common markers of physiological decline, such as muscle tears and neurological deficiencies, appeared to be mitigated for an extended period following routine exposure to the peptide
GLP-1 medications, such as Ozempic, Wegovy, Mounjaro, and Zepbound are now prescribed commonly for people diagnosed with Type 2 diabetes and/or obesity
M., Craft, S.,